Hansen Gwenn
Reporting owner on Forms 3, 4 and 5, CIK 1817160.
Hansen Gwenn reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NRIX · Nurix Therapeutics, Inc.CIK 1549595 | officer (Chief Scientific Officer) | 2 | 2026-11-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-11-02 | M exercised | +1,452 | $1.86 | 124,904 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-11-02 | S sold | -1,452 | $26.8 | 123,452 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-11-02 | M exercised | -1,452 | $0 | 57,954 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +3,750 | $0 | 120,977 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +2,859 | $0 | 123,836 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | M exercised | +3,573 | $0 | 127,409 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-30 | S sold | -3,957 | $26.2791 | 123,452 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -3,750 | $0 | 7,500 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -2,859 | $0 | 17,150 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Restricted Stock Units, derivative | 2026-10-30 | M exercised | -3,573 | $0 | 35,730 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-15 | M exercised | +1,452 | $1.86 | 118,679 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Common Stock | 2026-10-15 | S sold | -1,452 | $25 | 117,227 | Form 4 |
| NRIX · Nurix Therapeutics, Inc.Employee Stock Option (right to buy), derivative | 2026-10-15 | M exercised | -1,452 | $0 | 59,406 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001817160-26-000023 | Nurix Therapeutics, Inc. | 2026-11-02 | ||
| Form 4 0001817160-26-000021 | Nurix Therapeutics, Inc. | 2026-10-15 |